Show simple item record

dc.contributor.authorMulcaire, Jeffrey
dc.contributor.authorFauteux-Lamarre, Emmanuelle
dc.contributor.authorLee, Regina
dc.contributor.authorLynch, Karen
dc.contributor.authorShine, Ciara
dc.date.accessioned2024-08-21T16:29:35Z
dc.date.available2024-08-21T16:29:35Z
dc.date.issued2024-06
dc.identifier.citationMulcaire J, Fauteux-Lamarre E, Lee R, Lynch K, Shine C. Intranasal Fentanyl Guidance for Paediatric Patients. IAEM Guidelines 2024. https://iaem.ie/professional/clinical-guidelines/en_US
dc.identifier.urihttp://hdl.handle.net/10147/642681
dc.descriptionChildren frequently attend the Emergency Department (ED) with acute pain that requires rapid treatment as a result of an illness or injury. Pain relief should be provided quickly to treat pain effectively, and reduce stress caused to the child. Oligoanalgesia, and failure to reassess pain score have been repeatedly demonstrated in the management of acute pain in the paediatric population in EDs in national and international audits. Paediatric Emergency Research in the UK and Ireland (PERUKI) identified pain practice as a priority research domain, yet childhood pain management remains suboptimal with pain assessment documented in under 60% of children with minor injuries, and re-assessment of pain in just 11%.1 The intranasal (IN) route has been shown to be a non-invasive and effective method of drug administration to rapidly treat pain in children. IN medications can be drawn up in a syringe and administered immediately using the MAD® (Mucosal Atomiser Device) into one or two nostrils. IN administration of highly lipophilic drugs, such as fentanyl, has a rapid onset with direct entry into the cerebrospinal fluid (CSF) and brain. This avoids hepatic first-pass metabolism, making it an effective analgesic option for the treatment of children with acute moderate to severe pain, with its mode of administration causing minimal distress.en_US
dc.language.isoenen_US
dc.publisherIrish Association for Emergency Medicine (IAEM)en_US
dc.relation.ispartofseriesIAEM Clinical Guidelineen_US
dc.subjectHospitalsen_US
dc.subjectemergency medicineen_US
dc.subjectCHILDRENen_US
dc.subjectPAIN MANAGEMENTen_US
dc.titleIntranasal Fentanyl Guidance for Paediatric Patients [v1.0]en_US
dc.typeGuidelineen_US
refterms.dateFOA2024-08-21T16:29:37Z


Files in this item

Thumbnail
Name:
IN-Fentanyl-guideline-V1.0.pdf
Size:
918.2Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record